Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients
Status:
Completed
Trial end date:
2020-12-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety and of Once-Daily Tacrolimus
(TacroBell SR Cap.) in patients who received renal transplantation.